AI assistant
Sending…
Kezar Life Sciences, Inc. — Director's Dealing 2021
Dec 10, 2021
34845_dirs_2021-12-10_803a9e75-6c64-40d4-941c-bc26e0d94701.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2021-12-09
Reporting Person: Wallace Courtney (Director)
More from Kezar Life Sciences, Inc.
Delisting Announcement
2026
May 11
M&A Activity
2026
May 11
Interim / Quarterly Report
2026
May 11
Annual Report
2026
Apr 30
Legal Proceedings Report
2026
Apr 3
Merger & Acquisition
2026
Mar 30
M&A Activity
2026
Mar 30
Major Shareholding Notification
2026
Feb 9
Major Shareholding Notification
2025
Nov 14
Interim / Quarterly Report
2025
Nov 12